Inducing Paralysis in a Mouse Model via Transfer of Aquaporin-4-Specific Th17 Cells
JoVE Encyclopedia of Experiments
Neuroscience
0 views • 1:56 min • July 8th, 2025
Begin with a syringe containing T-helper or Th17 cells capable of recognizing an aquaporin-4 protein of astrocytes in the CNS, including the spinal cord, which plays a role in signal transmission to the brain.
Inject these Th17 cells into the tail vein of a restrained mouse. The cells enter the bloodstream and circulate throughout the body.
Simultaneously, intraperitoneally administer a bacterial toxin derived from the Bordetella pertussis.
The toxin disturbs the endothelial barrier of blood vessels and allows Th17 cells to infiltrate the spinal cord.
The infiltrated Th17 cells interact with the astrocytes expressing the aquaporin-4 and become activated.
These activated cells release pro-inflammatory cytokines, which causes the infiltration of mononuclear immune cells, including macrophages.
Macrophages release inflammatory molecules that damage the myelin sheath of the surrounding nerve fibers.
This demyelination disrupts nerve signal transmission, leading to tail stiffness and restricted hind limb movement, indicating the onset of paralysis.
Within one hour of their collection, transfer the cells into a 1-milliliter syringe and deliver 200 microliters of cells to each recipient animal intravenously through the tail vein. Then, inject each mouse intraperitoneally immediately, and two days later, with 200 nanograms of B. pertussis toxin diluted in 200 microliters of PBS.
Overview
This study investigates the role of Th17 cells in demyelination and paralysis in a mouse model. By injecting Th17 cells and a bacterial toxin, the research explores the inflammatory response and its effects on nerve signal transmission.
Key Study Components
Area of Science
- Neuroscience
- Immunology
- Neuroinflammation
Background
- Th17 cells are a subset of T-helper cells involved in autoimmune responses.
- Aquaporin-4 is a protein expressed by astrocytes in the central nervous system.
- Demyelination can disrupt nerve signal transmission, leading to paralysis.
- Bordetella pertussis toxin affects the endothelial barrier, facilitating immune cell infiltration.
Purpose of Study
- To understand the mechanism of Th17 cell-mediated demyelination.
- To investigate the inflammatory response in the spinal cord.
- To assess the impact of Th17 cells on motor function in mice.
Methods Used
- Injection of Th17 cells into the tail vein of restrained mice.
- Administration of Bordetella pertussis toxin intraperitoneally.
- Monitoring of motor function and signs of paralysis.
- Analysis of immune cell infiltration and cytokine release.
Main Results
- Th17 cells infiltrated the spinal cord following toxin administration.
- Activated Th17 cells released pro-inflammatory cytokines.
- Infiltration of macrophages led to myelin sheath damage.
- Mice exhibited tail stiffness and restricted hind limb movement.
Conclusions
- Th17 cells play a critical role in the inflammatory process leading to demyelination.
- The study provides insights into the mechanisms of paralysis in autoimmune conditions.
- Further research may explore therapeutic targets for demyelinating diseases.
Frequently Asked Questions
Executive Industry Relevance
This model enables mechanistic interrogation of Th17-mediated neuroinflammation, supporting target validation in autoimmune demyelinating diseases. By recapitulating aquaporin-4-specific immune pathogenesis, it provides a disease-relevant system for preclinical de-risking of immunomodulatory candidates. The approach aids in assessing target engagement and pathway modulation prior to lead optimization.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables functional validation of aquaporin-4 as a pathogenic target in CNS autoimmunity.
- Operational Value: Provides a reproducible system to interrogate Th17 cell pathogenicity and cytokine-mediated effector functions.
- Strategic Value: Supports target de-risking by linking immune cell specificity to demyelination and motor deficits.
Screening & Assay Development
- Scientific Value: Generates quantifiable neuroinflammatory readouts including cytokine profiles and immune cell infiltration.
- Operational Value: Standardizes induction of CNS immune infiltration via defined cellular and toxin co-administration.
- Strategic Value: Enables consistent compound screening for immunomodulatory effects on Th17-mediated pathology.
Translational & Preclinical Research
- Scientific Value: Models human neuromyelitis optica spectrum disorder pathogenesis through antigen-specific T-cell transfer.
- Operational Value: Facilitates longitudinal assessment of demyelination and neurological deficit progression.
- Strategic Value: Informs go/no-go decisions by correlating target modulation with functional recovery in a disease-relevant system.
Pipeline & Workflow Integration
The method fits within the discovery-to-preclinical continuum, enabling immune mechanism validation prior to lead identification and efficacy testing in disease models.
- Discovery Biology: Supports hypothesis testing of Th17 cell pathogenicity and antigen-specific CNS targeting.
- Screening: Delivers standardized immune infiltration and cytokine release metrics for compound profiling.
- Analytics: Provides quantitative endpoints including motor function scoring, demyelination assessment, and immune infiltrate quantification.
- Translational Research: Connects immune mechanism to clinical-relevant outcomes like paralysis and blood-brain barrier disruption.
- Enterprise Reuse: Establishes a modular platform for testing immunomodulators across antigen-specific autoimmune indications.
Operational & Enterprise Impact
- Scientific Value: Mechanistic de-risking of aquaporin-4 and Th17 pathway targets through causal linkage to demyelination.
- Operational Value: Reproducible induction of neuroinflammation via defined cellular transfer and permeability-modulating toxin.
- Strategic Value: Enables predictive confidence in target selection by validating autoimmune effector mechanisms in vivo.
- Portfolio Impact: Supports risk-adjusted prioritization of immunomodulators based on target engagement and pathway inhibition.
Implementation Considerations
- Requires expertise in immunology, cell culture, and in vivo neuroinflammatory modeling.
- Dependent on sterile Th17 cell preparation, intravenous injection precision, and toxin handling protocols.
- Necessitates standardized scoring of motor deficits and histopathological validation across study sites.
- Adaptation to alternative antigens or models requires validation of target specificity and immune infiltration efficiency.
- Practical limitations include variability in cell activation status and toxin bioavailability affecting penetration consistency.
Biopharma FAQs
Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues
Related Videos
0 Views
Human Serum Anti-aquaporin-4 Immunoglobulin G Detection by Cell-based Assay
Related Videos
0 Views
Investigation of Spatial Interaction Between Astrocytes and Neurons in Cleared Brains
Related Videos
0 Views
Targeted Drug Delivery in a Mouse Model via Cisterna Magna Injection
Related Videos
0 Views
Induction of Experimental Autoimmune Encephalomyelitis in a Mouse Model
Related Videos
0 Views
Generation of Experimental Autoimmune Encephalomyelitis in a Mouse Model
Related Videos
0 Views
Induction of Experimental Autoimmune Encephalomyelitis in a Mouse Model
Related Videos
0 Views
Intrathecal Delivery of Viruses in a Mouse Model for Treating Central Nervous System Diseases
Related Videos
0 Views
Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
Related Videos
0 Views
Adeno-associated Virus-mediated Transgene Expression in Genetically Defined Neurons of the Spinal Cord
Related Videos
0 Views
Last updated: 29 August 2026